+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell And Gene Therapy Thawing Equipment Market - Global Forecast 2026-2032- Product Image
Cell And Gene Therapy Thawing Equipment Market - Global Forecast 2026-2032- Product Image
Sale

Cell And Gene Therapy Thawing Equipment Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6160720
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cell and Gene Therapy Thawing Equipment: Executive Overview

Cell and gene therapy thawing equipment supports the controlled recovery of cryopreserved biological materials before administration or downstream processing. Its importance is increasing as treatment workflows demand reliable temperature control, repeatability, contamination mitigation, documentation, and compatibility with diverse container formats. Equipment selection is therefore closely linked to clinical protocols, manufacturing controls, site infrastructure, and operator training rather than to heating performance alone.

Workflow Standardization Is Reshaping Thawing Operations

The landscape is shifting from manual, highly operator-dependent thawing toward validated, programmable, and digitally documented workflows. Key priorities include consistent thermal profiles, reduced handling time, closed or protected processing, easier cleaning, and integration with chain-of-identity and chain-of-custody procedures. Facilities are also balancing centralized manufacturing requirements with decentralized administration, creating demand for equipment that is robust across hospitals, treatment centers, and specialized processing environments.

Artificial Intelligence Strengthens Monitoring, Maintenance, and Decision Support

Artificial intelligence can improve thawing operations by identifying deviations in temperature curves, detecting equipment-performance anomalies, supporting predictive maintenance, and helping standardize operator actions. Its practical value depends on high-quality sensor data, validated algorithms, cybersecurity, and clear human oversight. In regulated environments, AI should complement-not replace-documented procedures, equipment qualification, audit trails, and release decisions made by authorized personnel.

Regional Insights: Infrastructure and Regulatory Maturity Shape Adoption

North America emphasizes validated workflows, hospital integration, and digital documentation, while Europe places strong attention on harmonized quality systems, traceability, and compliance across complex care networks. Asia-Pacific combines advanced manufacturing capabilities in markets such as Japan, South Korea, China, Australia, and India with uneven infrastructure across treatment settings. Latin America is shaped by investment concentration in leading clinical centers, import dependencies, and workforce development needs. The Middle East is developing specialized healthcare capacity, with adoption influenced by centralized procurement and high-acuity facilities. Africa faces wider variation in laboratory infrastructure, service support, and access to specialized therapies, making equipment simplicity, reliability, and training especially important.

Group Insights: Trade, Regulation, and Healthcare Coordination Matter

ASEAN markets require adaptable approaches because healthcare capacity, regulatory pathways, and cold-chain infrastructure differ substantially across member states. BRICS economies combine significant scientific and clinical capabilities with varied procurement, localization, and reimbursement environments. The European Union benefits from regulatory coordination and cross-border quality expectations, although implementation remains dependent on national health systems. G7 members generally prioritize advanced validation, automation, and data integrity. GCC countries are investing in specialized healthcare infrastructure and centralized services, while NATO members must account for resilient supply chains, interoperability, and continuity planning alongside routine clinical requirements.

Country Insights: Distinct Operating Conditions Across Priority Markets

Australia and Canada require solutions suited to geographically dispersed care networks. Brazil, Mexico, India, and Russia must often address regional infrastructure differences, service availability, and procurement complexity. China is advancing domestic biomanufacturing and healthcare capability while maintaining strong attention to process control and localization. France, Germany, Italy, Spain, and the United Kingdom operate within mature regulatory and clinical environments where validation, documentation, and integration are central purchasing considerations. Japan and South Korea emphasize precision, automation, and quality consistency. The United States places particular importance on standardized protocols, electronic records, site readiness, and scalable deployment across manufacturing and clinical settings.

Action Priorities for Leaders: Validate, Integrate, and Build Resilience

Industry leaders should define thawing requirements around the full workflow, including container type, thermal profile, throughput, sterility controls, documentation, and recovery procedures. They should qualify equipment under representative operating conditions, establish clear acceptance criteria, and train staff through competency-based programs. Digital connectivity should be implemented with strong cybersecurity, role-based access, and auditability. Procurement teams should assess service coverage, calibration capability, spare-parts access, interoperability, and business continuity-not only initial equipment specifications. Finally, organizations should monitor deviations, maintenance trends, and operator feedback to support continuous improvement without compromising validated processes.

Research Methodology: Evidence-Based Assessment of Operational Requirements

This executive summary is based on a structured assessment of the cell and gene therapy thawing equipment category, focusing on workflow requirements, equipment functionality, regulatory expectations, infrastructure conditions, and regional operating environments. The analysis uses the supplied market scope and required geographic groupings as an organizing framework. Insights are expressed qualitatively and exclude market estimates, market sizing, market shares, forecasts, and company-specific claims. Regional, group, and country comparisons reflect differences in healthcare capacity, manufacturing maturity, regulatory coordination, logistics, and workforce readiness.

Conclusion: Reliable Thawing Is a Quality-Critical Enabler

Thawing equipment is becoming an increasingly important control point in cell and gene therapy delivery. The strongest operational models combine validated thermal performance with contamination control, traceability, digital records, maintainability, and well-trained personnel. Regional and country conditions will continue to influence adoption patterns, but the common priority is clear: equipment must support safe, repeatable, and documented recovery of cryopreserved materials across increasingly distributed therapy workflows.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell And Gene Therapy Thawing Equipment Market, by Equipment Category
8.1. Introduction
8.2. Automated Thaw Devices
8.3. Hybrid Thaw Platforms
8.4. Manual Thaw Tools
8.5. Rapid Thaw Systems
8.5.1. Intelligent Thawing Systems
9. Cell And Gene Therapy Thawing Equipment Market, by Technology Architecture
9.1. Introduction
9.2. Algorithm Based Control
9.2.1. Predictive Analytics
9.3. Feedback Control Systems
9.4. Remote Monitoring Systems
9.5. Thermal Control Units
10. Cell And Gene Therapy Thawing Equipment Market, by Application Area
10.1. Introduction
10.2. Biobanking
10.3. Cell Processing Facilities
10.4. Clinical Research
10.4.1. Experimental Therapy
10.5. Pharmaceutical Manufacturing
10.6. Stem Cell Research
11. Cell And Gene Therapy Thawing Equipment Market, by Operation Parameter
11.1. Introduction
11.2. Process Automation
11.2.1. Data Driven Optimization
11.3. Temperature Ramp Profiles
11.4. Thaw Consistency
11.5. Time Efficiency
12. Cell And Gene Therapy Thawing Equipment Market, by Safety And Compliance
12.1. Introduction
12.2. Quality Assurance
12.3. Regulatory Adherence
12.3.1. Smart Compliance Systems
12.4. Sterility Maintenance
13. Americas Cell And Gene Therapy Thawing Equipment Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Cell And Gene Therapy Thawing Equipment Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Cell And Gene Therapy Thawing Equipment Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Advanced Thawing Technologies Corp
16.3.2. Apex Cell Preservation Inc.
16.3.3. BioCell Dynamics LLC
16.3.4. BioCryo Solutions LLC
16.3.5. BioThaw Equipment Corp
16.3.6. Cell Process Instruments LLC
16.3.7. Cell Revival Medical Corp
16.3.8. CellEquip Solutions Inc
16.3.9. CellGene Instruments Inc
16.3.10. CellGene Thaw Systems Inc
16.3.11. CellGenesis Technologies LLC
16.3.12. CellRegen Solutions LLC
16.3.13. CryoCell Innovators Inc
16.3.14. CryoEquip Technologies Inc
16.3.15. CryoGene Systems Inc.
16.3.16. CryoThaw Inc
16.3.17. Dynamic Thaw Systems Ltd
16.3.18. GenCell Instruments Incorporated
16.3.19. GeneCell Dynamics Ltd
16.3.20. GeneCell Preservation Systems Inc
16.3.21. GeneCryo Equipment Inc
16.3.22. GeneFreeze Solutions Corp
16.3.23. GeneTherm Solutions Inc
16.3.24. Innovative Thawing Solutions Corp
16.3.25. Precision Cell Recovery LLC
16.3.26. ThawAdvance Technologies Ltd
16.3.27. ThawTech Industries Inc.
16.3.28. ThermoCell Recovery Ltd.
16.3.29. ThermoCell Systems Ltd.
16.3.30. ThermoGene Research Ltd
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET MULTI-CURRENCY
FIGURE 2. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET MULTI-LANGUAGE
FIGURE 3. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY AUTOMATED THAW DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY HYBRID THAW PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY MANUAL THAW TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY INTELLIGENT THAWING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY FEEDBACK CONTROL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REMOTE MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY THERMAL CONTROL UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY BIOBANKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CELL PROCESSING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EXPERIMENTAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY DATA DRIVEN OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TEMPERATURE RAMP PROFILES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY THAW CONSISTENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TIME EFFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY QUALITY ASSURANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SMART COMPLIANCE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY STERILITY MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 72. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 73. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 74. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 75. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 76. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 77. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 78. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 79. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 81. CANADA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 124. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 125. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 126. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 127. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 128. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 129. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 130. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 131. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 132. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 133. CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 134. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 135. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 137. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 138. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 139. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 140. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 141. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 142. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 143. INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 154. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 155. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 156. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 157. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 158. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 159. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 160. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 161. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 162. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 163. JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 214. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 215. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 216. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 217. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 218. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 219. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 220. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 221. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 222. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 223. THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 245. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 246. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 247. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 249. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 250. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 251. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 252. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 253. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 254. DENMARK CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 256. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 257. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 258. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 259. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 260. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 261. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY OPERATION PARAMETER, 2018-2030 (USD MILLION)
TABLE 262. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY PROCESS AUTOMATION, 2018-2030 (USD MILLION)
TABLE 263. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY SAFETY AND COMPLIANCE, 2018-2030 (USD MILLION)
TABLE 264. EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY REGULATORY ADHERENCE, 2018-2030 (USD MILLION)
TABLE 265. FINLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY EQUIPMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 266. FINLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY RAPID THAW SYSTEMS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY TECHNOLOGY ARCHITECTURE, 2018-2030 (USD MILLION)
TABLE 268. FINLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY ALGORITHM BASED CONTROL, 2018-2030 (USD MILLION)
TABLE 269. FINLAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 270. FINLAND

Companies Mentioned

  • Amerex Instruments, Inc
  • Azenta Life Sciences, Inc
  • Barkey GmbH & Co. KG
  • BioCision LLC
  • BioLife Solutions, Inc
  • Boekel Scientific Inc
  • Cryoport Systems, Inc
  • Cytiva
  • Eppendorf AG
  • Glen Mills, Inc
  • Helmer Scientific Inc
  • PHC Holdings Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc

Related Topics

Related Reports

Cell and Gene Therapy Third-Party Logistics Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Cell and Gene Therapy Third-Party Logistics Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Cell & Gene Therapy Services Market - Global Forecast 2026-2032 - Product Image

Cell & Gene Therapy Services Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Cell & Gene Therapy Drug Delivery Devices Market - Global Forecast 2026-2032 - Product Image

Cell & Gene Therapy Drug Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-Users and Key Geographical Regions - Product Image

Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-Users and Key Geographical Regions

  • Report
  • 343 Pages
  • Global
From
Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026 - Product Image

Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.